Harvestfield Begins Local Production of Next-Generation Malaria Nets

BY RAQIIB TEMIDAYO
Harvestfield Healthcare FZE has commenced commercial production of next-generation insecticide-treated mosquito nets in Nigeria, opening a new chapter in the country’s efforts to strengthen domestic manufacturing of critical malaria-control products.
The company began operations at its manufacturing facility in the Harvestfield Free Trade Zone, Ogun State, on September 13, 2026, with the plant already supplying a World Bank-funded malaria programme covering 31 states.
The facility is the first wholly Nigerian-owned manufacturing plant in the country producing dual active ingredient long-lasting insecticidal nets of the pyrethroid-chlorfenapyr class.
Harvestfield is manufacturing the nets under an agreement with GDM Health Products, producer of Synera DuoForte, a World Health Organisation (WHO)-prequalified dual active ingredient long-lasting insecticidal net.
The development comes against the backdrop of growing pyrethroid resistance among mosquito populations, which has reduced the effectiveness of conventional insecticide-treated nets in some parts of Nigeria.
Unlike conventional nets that rely primarily on pyrethroid insecticides, dual active ingredient nets combine a pyrethroid with a second insecticide that works through a different mode of action.
According to the company, the technology is designed to maintain insecticidal effectiveness in areas where mosquitoes have developed resistance to pyrethroids, with the WHO recommending the class of net for areas with established pyrethroid resistance..
Synera DuoForte is developed and owned by GDM Health Products and is under WHO prequalification, while Harvestfield’s Ogun State manufacturing site has been included as an approved manufacturing location under the product’s prequalification.
The facility is also certified by the National Agency for Food and Drug Administration and Control (NAFDAC) and holds ISO certification, providing the quality and regulatory framework required for production for national malaria programmes and other health interventions..
Commenting on the partnership, Jon Bastow, a representative of GDM Health Products, said the company was pleased to work with Harvestfield to bring Synera DuoForte production to Nigeria.
“GDM is pleased to strategically partner with Harvestfield to bring Synera DuoForte to Nigeria, the country with the biggest global malaria burden, and support the prequalification of Harvestfield’s Ogun State manufacturing facility to make Synera DuoForte,” he said.
The Coordinating minister of Health and Social Welfare, Professor Muhammad Ali Pate, described the development as an important step towards strengthening Nigeria’s health security through domestic production.
“Building the capacity to manufacture our own health products is central to Nigeria’s health security. A Nigeria-based facility producing next-generation insecticide-treated nets to international standard, and already supplying programmes across thirty-one states, is the kind of capability the Renewed Hope agenda was created to build,” Pate said.
The investment marks a strategic transition for Harvestfield, which has operated in Nigeria’s vector-control sector for 26 years.
The company said the Harvestfield group has delivered more than 42 million insecticide-treated nets across all 36 states and has served as an exclusive national distribution partner for WHO-prequalified nets since 2018.
The move into manufacturing is expected to strengthen the domestic supply chain for insecticide-treated nets by reducing dependence on overseas production and shipping schedules.
Harvestfield said, imported nets can require between 45 and 60 days to arrive by sea, creating potential delays in responding to changing malaria-control requirements.
Local production, it added, would provide greater flexibility to respond to malaria-control needs and changing patterns of insecticide resistance while strengthening technical, manufacturing, quality-control and regulatory capabilities within Nigeria.
Dr Abdul Mukhtar of the Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC) said local manufacturing was central to reducing Nigeria’s dependence on imported health products.
“PVAC exists to move Nigeria from importing its health products to making them. What matters is not only that a factory exists, but that it meets the standards international buyers accept and can supply at national scale,” he said.
“A facility based in Nigeria doing both is precisely the outcome this initiative was created to unlock.”
Harvestfield said the new plant would serve as the first platform in a broader effort to develop healthcare manufacturing capacity in Nigeria, with the technical and regulatory infrastructure potentially supporting the production of other health products in the future.
The investment aligns with the Federal Government’s push to increase domestic production of healthcare products under the Renewed Hope health agenda, PVAC and the Nigeria First procurement policy.
With malaria remaining a major public-health challenge in Nigeria, the commencement of local production of next-generation insecticide-treated nets places domestic manufacturing, technology transfer and resistance-responsive malaria prevention at the centre of the country’s evolving healthcare value chain.


